Straumann Holding Ag · SIX:STMN
Straumann — Q3 2013 Earnings Presentation
14 slides from Straumann's earnings presentation, Oct 31, 2013
Slide 1: 9-months and third-quarter 2013 results
9-months and third-quarter 2013 results Analysts’ & Media Conference Call Basel, 31 October 2013 Disclaimer This presentation contains certain “forward-looking statements”, which can be identified by the use of terminology such as “will”, “guidance”, “would”, “prevailing”, “still be able to”, “shoul
Slide 2: Highlights
Highlights Marco Gadola CEO Highlights – sustained growth in Q2 and Q3 makes up for soft Q1 Revenue 9M Revenue Q3 Best performer CHF 510m CHF 155m Rest of World in line with prior year (organic1) +3% organic growth Region grows 35% in Q3 Main contributor Strategic progress Pipeline N. America Invest
Slide 3: Business performance
Business performance Thomas Dressendörfer CFO Solid 9-month performance outside Europe in CHF m (1.6%) in CHF 0.3% organic (5.8) (4.2) (10.8) 9.1 0.9 2.3 518.5 508.5 510.0 Change organic (1.1%) (0.8%) (3.8%) 7.1% 1.3% 10.1% Revenues 9M FX Effect iTero Effect Revenues 9M Europe North APAC ROW Revenue
Slide 4: Quarterly growth trend vs. key competitors
Quarterly growth trend vs. key competitors 25% 20% 15% 10% 5% 0% -5% -10% -15% Straumann organic growth Market for tooth replacement & restoration (leading implant companies) * * Straumann, Nobel Biocare, Zimmer Dental, Biomet 3i, Dentsply Implants - based on company and SEC Straumann reports as w
Slide 5: North America
Above-market growth in N. America; Europe still soft Revenue change (organic) Q3 revenue contracts 3% (l.c.) Europe France, UK and distributor markets 56%0.2% continue to perform well (3.4%) (5.3%) (5.6%) (7.7%) Italy, Germany, Netherlands and Iberia unable to meet prior year level Q3 Q4 Q1 Q2
Slide 6: Strategic initiatives to expand into the value segment
Strategic initiatives to expand into the value segment Marco Gadola CEO Value strategy – capturing opportunities, limiting damage Increase in local/regional players offering lower-priced lookalikes/alternatives To capture significant opportunity in the value segment, Straumann is building a plat
Slide 7: Value platform offering both implants and prosthetics
Value platform offering both implants and prosthetics STRAUMANN HOLDING AG Premium segment Value segment Neodent Dental Medentika Wings Steering Committee Createch Implant Co. X Prosth. Co. Y Straumann 13 Medentika Based in Germany, founded 2005, privately owned Fast-growing provider of cost-e
Slide 8: Createch and Neodent brand established in Spain
Createch Founded 2006; located in Mendaro (Spain); 30 employees Produces high quality specialized CADCAM prosthetics; premium image Sales mainly domestic; expanding to Germany and Netherlands R&D focus for implant-borne prosthetics 30% acquired for undisclosed sum CADCAM bridges, bars, abu
Slide 9: New solutions and product launches
Who plays where? IMPLANTS PROSTHETICS REGENERATIVES Straumann 17 New solutions and product launches 9
Slide 10: Solutions presented/launched to tap growth opportunities
Solutions presented/launched reflecting efforts to tap into exciting growth opportunities New ceramic Roxolid/SLActive implant 4mm implant Surgeons High-tech Ceramic implants Smaller, less Fixed invasive immediate implants edentulous GPs solutions Implants for narrow spaces Esthetic, fast implant so
Slide 11: New 4mm Short Implant and ceramic implant
New 4mm Short Implant Indications addressed by implant dentistry expand 2000 – 2013 2013 and beyond Roxolid/SLActive Tissue Level design High performance short implant opens new treatment options for patients with insufficient vertical bone for conventional implants Extraction sites Partially ed
Slide 12: Agreement with 3Shape; Outlook 2013 and beyond
Agreement with 3Shape broadens prosthetic options with guaranteed precision and reliability With new software library and Straumann® Variobase kit, 3Shape scanner users can produce custom abutments with precise original connections for Straumann implants Straumann emphasizes view that original c
Slide 13: Questions? Currency headwind and revenue breakdown
Questions? Slight currency headwind expected for the full year Revenue breakdown 2012 Average exchange rates (rounded) CHF 11% FY 2012 9M 2013 EURCHF 1.21 1.22 Other EUR 21% 41% USDCHF 0.93 0.91 JPYCHF 1.17 0.92 Straumann’s major exchange rates since 2012 (indexed to 100) USD/CAD/AUD 27% 110 Cost br
Slide 14: Calendar of upcoming events; Your contacts
Calendar of upcoming events 2013 01 November Investor meetings Zurich 2014 25 February Full-year results conference Basel 11 April Annual General Meeting Basel 30 April First quarter sales Webcast Detailed calendar on www.straumann.com Straumann 27 Your contacts Fabian Hildbrand Corporate Investor